Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysis
PA-TACE improves RFS and OS of HCC patients after liver resection, especially in MVI-positive patients. Furthermore, PA-TACE reduces the malignancy of recurrent tumors.
Authors
- Yang Xin-rong
- Y Chen
- Lei Zhang (ORCID: https://orcid.org/0000-0001-5369-5756)
- Jia-jun Li
- Maopei Chen (ORCID: https://orcid.org/0000-0001-9998-7770)
- Rongxin Chen (ORCID: https://orcid.org/0000-0001-7537-0661)
- Ning-Ling Ge
- Ye Xu
- Hua-Hua Liu
- Zheng-Gang Ren
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/jgo-2025-655
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00